Skip to main content

Table 2 Spearman rank order correlations for PET amyloid deposition and immune profile in aMCI subjects

From: Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment

     

Cerebrospinal fluid (CSF)

Peripheral blood (PB)

 

Age

PET-PCC

PET-precuneous

PET-mean

42

IL6

IgG

CD4 T cell

%

B cell

%

Memory B cell%

Plasmab

%

T cell #

CD4 T cell #

CD4:CD8

CD4 T cell%

B cell

%

CD4:CD8

Age

 

0.66**

0.54*

0.20

−0.20

0.63*

−0.22

0.49*

0.29

0.39

0.60**

−0.28

−0.30

−0.39

0.10

−0.32

0.07

PET-PCC

(0.002)

 

0.49*

0.49*

−0.51*

0.66*

0.20

−0.35

0.25

0.16

0.28

0.57*

0.54*

−0.20

0.16

−0.28

0.12

PET-precuneous

(0.013)

(0.029)

 

0.73**

−0.36

−0.45

0.002

−0.39

0.10

0.38

0.39

−0.12

−0.21

−0.22

−0.34

0.58**

−0.32

PET-mean

(0.39)

(0.027)

(<0.0001)

 

−0.52*

−0.06

0.04

−0.31

0.09

0.56*

0.18

−0.13

−0.22

−0.05

−0.33

−0.43

−0.35

CSF | Aβ42

(0.38)

(0.030)

(0.14)

(0.029)

 

0.04

0.45*

0.17

−0.17

−0.40

−0.23

0.35

0.39

0.36

0.17

0.23

0.25

CSF | IL6

(0.027)

(0.038)

(0.19)

(0.88)

(0.90)

 

0.17

0.68

−0.02

−0.51

−0.52

0.16

0.13

0.34

0.01

0.57

0.14

CSF | IgG

(0.33)

(0.44)

(0.99)

(0.88)

(0.04)

(0.62)

 

−0.10

−0.19

−0.39

−0.16

−0.35

−0.25

−0.01

0.29

−0.06

0.22

CSF | CD4 T cell (%)

(0.047)

(0.22)

(0.17)

(0.28)

(0.52)

(0.86)

(0.70)

 

−0.46

−0.05

−0.21

0.47

0.59*

0.67**

−0.09

0.28

−0.08

CSF | B cell (%)

(0.21)

(0.34)

(0.69)

(0.72)

(0.46)

(0.95)

(0.44)

(0.06)

 

−0.02

0.17

−0.47

−0.56*

−0.18

0.09

−0.16

−0.01

CSF | memory B (%)

(0.09)

(0.54)

(0.13)

(0.02)

(0.08)

(0.11)

(0.10)

(0.85)

(0.93)

 

0.37

0.08

0.01

−0.32

0.54*

−0.34

0.63**

CSF | plasmablasts (%)

(0.005)

(0.28)

(0.12)

(0.49)

(0.33)

(0.10)

(0.50)

(0.42)

(0.47)

(0.11)

 

−0.04

−0.08

−0.49*

0.09

−0.43

−0.08

CSF | T cell (#)

(0.27)

(0.034)

(0.68)

(0.65)

(0.17)

(0.68)

(0.17)

(0.06)

(0.06)

(0.76)

(0.87)

 

0.95**

0.37

−0.21

0.30

−0.08

CSF | CD4 T cell (#)

(0.25)

(0.046)

(0.47)

(0.44)

(0.12)

(0.74)

(0.34)

(0.01)

(0.019)

(0.99)

(0.75)

(<0.0001)

 

0.50*

−0.14

0.09

−0.03

CSF | CD4:CD8

(0.13)

(0.49)

(0.45)

(0.86)

(0.15)

(0.37)

(0.97)

(0.003)

(0.49)

(0.20)

(0.05)

(0.14)

(0.04)

 

0.13

0.17

0.19

PB | CD4T (%)

(0.68)

(0.56)

(0.20)

(0.22)

(0.48)

(0.97)

(0.22)

(0.73)

(0.72)

(0.026)

(0.74)

(0.41)

(0.60)

(0.63)

 

0.20

0.94**

PB | B cell (%)

(0.13)

(0.23)

(0.007)

(0.06)

(0.30)

(0.05)

(0.79)

(0.28)

(0.49)

(0.14)

(0.06)

(0.24)

(0.72)

(0.51)

(0.40)

 

0.18

PB | CD4:CD8

(0.76)

(0.65)

(0.22)

(0.19)

(0.31)

(0.70)

(0.37)

(0.75)

(0.99)

(0.007)

(0.77)

(0.76)

(0.91)

(0.45)

(<0.0001)

 

0.18

  1. In the rho-value section of the table, rho-values that are significant are in italics and * = <0.05 and ** = <0.01. Specific p-values are in parenthesis with significant values in italics